Dr. Dre, The Chronic Full Album Zip
Another copyright-related lawsuit hit Dr. Dre in the fall of 2002, when Sa Re Ga Ma, a film and music company based in Calcutta, India, sued Aftermath Entertainment over an uncredited sample of the Lata Mangeshkar song "Thoda Resham Lagta Hai" on the Aftermath-produced song "Addictive" by singer Truth Hurts. In February 2003, a judge ruled that Aftermath would have to halt sales of Truth Hurts' album Truthfully Speaking if the company would not credit Mangeshkar.
Dr. Dre, The Chronic Full Album Zip
Planned but unreleased albums during Dr. Dre's tenure at Aftermath have included a full-length reunion with Snoop Dogg titled Breakup to Makeup, an album with fellow former N.W.A member Ice Cube which was to be titled Heltah Skeltah, an N.W.A reunion album, and a joint album with fellow producer Timbaland titled Chairmen of the Board.
Upon leaving Ruthless and forming Death Row Records in 1991, Dre called on veteran West Coast DJ Chris "the Glove" Taylor and sound engineer Greg "Gregski" Royal, along with Colin Wolfe, to help him on future projects. His 1992 album The Chronic is thought to be one of the most well-produced hip-hop albums of all time. Musical themes included hard-hitting synthesizer solos played by Wolfe, bass-heavy compositions, background female vocals and Dre fully embracing 1970s funk samples. Dre used a minimoog synth to replay the melody from Leon Haywood's 1972 song "I Wanna Do Somethin' Freaky to You" for the Chronic's first single "Nuthin' but a 'G' Thang" which became a global hit. For his new protégé Snoop Doggy Dogg's album Doggystyle, Dre collaborated with then 19-year-old producer Daz Dillinger, who received co-production credits on songs "Serial Killa" and "For all My Niggaz & Bitches", The Dramatics bass player Tony "T. Money" Green, guitarist Ricky Rouse, keyboardists Emanuel "Porkchop" Dean and Sean "Barney Rubble" Thomas and engineer Tommy Daugherty, as well as Warren G and Sam Sneed, who are credited with bringing several samples to the studio.
A consequence of his perfectionism is that some artists who initially sign deals with Dr. Dre's Aftermath label never release albums. In 2001, Aftermath released the soundtrack to the movie The Wash, featuring a number of Aftermath acts such as Shaunta, Daks, Joe Beast and Toi. To date, none have released full-length albums on Aftermath and have apparently ended their relationships with the label and Dr. Dre. Other noteworthy acts to leave Aftermath without releasing albums include King Tee, 2001 vocalist Hittman, Joell Ortiz, Raekwon and Rakim.
Legendary 7X GRAMMY and Emmy Award-winning artist/producer Dr. Dre celebrates the 30th anniversary of his magnum opus, The Chronic by announcing the album will be re-released by its original distributor, Interscope Records which worked The Chronic in 1992 via its relationship with Death Row Records.The Chronic, which is not currently available on streaming services, will again be available to fans on all major DSPs today, February 1, 2023. The re-release of the acclaimed work will be accompanied by a special Chronic merch collection which will be available here."I am thrilled to bring the Chronic home to its original distribution partner, Interscope Records. Working alongside my longtime colleagues, Steve Berman and John Janick, to re-release the album and make it available to fans all over the world is a full circle moment for me," said Dr. Dre.Steve Berman, Vice Chairman of Interscope Geffen A&M, said: "Dr. Dre is without a doubt one of the most iconic and groundbreaking artists in the modern era. He has also used his platform to fuel some very impactful philanthropic efforts that will ensure his legacy is felt for generations to come.
Speaker 1: 00:00 Using technology to track COVID-19 in the body. ThisSpeaker 2: 00:04 Gives further evidence that long COVID is really impacting many individuals who come down with COVIDSpeaker 1: 00:11 I'm Jayden, even with Maureen Kavanaugh, this is KPBS good day edition. What's driving a rise in fentanyl use.Speaker 2: 00:27 We're sort of catching up in San Diego now that it's easier for it to be coming here. And now I think we're just seeing a continuing legacy of that. That's been exacerbated by the pandemic.Speaker 1: 00:40 The university of California is taking in more students. And have you ever wanted to fight zombies will take you to a new virtual reality gaming facility that's ahead on midday edition. First, the newsSpeaker 3: 01:01 Scripts uses activity trackers to spot COVID symptoms and side effects. And why deadly fentanyl is becoming a popular drug. I'm Maureen Kavanaugh with Dre Hyman. This is KPBS mid-day edition. It's Wednesday, July 7th.Speaker 1: 01:27 Can your smart watch or Fitbit detect COVID-19 before symptoms appear? And can those devices tell you how your body is recovering emerging data from an ongoing study with script's research, translational Institute says it's quite possible. Scientists are using activity trackers to look at the physiological and behavioral changes that happened just before symptoms appear and extend months after the infection is gone. Jennifer Raiden is an epidemiologist with the digital medicine division at scripts, and she is leading. What's called the detect study. Uh, Dr. RadenSpeaker 2: 02:01 Welcome. Thank you for having me.Speaker 1: 02:03 You are finding common technology like smartwatches to be very helpful and understanding how he COVID-19 infection impacts the body. What have you discovered from people who are wearing these activity trackers?Speaker 2: 02:16 Yeah, so activity trackers can really give us a better view into each individual's unique, normal resting heart rate activity, and sleep patterns when they're healthy. And so when someone comes down with a viral infection, such as COVID, we can identify, um, changes compared to each user's unique, normal to better understand how they are responding to an infection in our current study that just came out. We looked at people's recovery patterns. Um, so how long it took them to go back to their baselines for resting heart rate activity and sleep. And what we found was that on average, it took, um, participants who came down with COVID about two to three months to return to their baseline resting heart rate. Mm.Speaker 1: 03:04 And how do these new findings compare to the current understanding of the impacts of COVID on the body?Speaker 2: 03:10 Yeah. So this is the first time that we've really been able to collect continuous longitudinal objective data from purchase of Pence, to be able to understand what their healthy normal was prior to infection, and then really, uh, follow them continuously over time to really see how their body responded to the infection and how long it is taking to recover. And so this gives further evidence that long COVID is really impacting many individuals who come down with COVID the detectSpeaker 1: 03:43 Study previously found that, that these devices may also be able to tell if there's an infection before symptoms show up. HowSpeaker 2: 03:50 So? Yeah. So, um, when people come down with a viral illness, they may start to see a subtle small change in the resting heart rate, um, even before fever onset or different symptom onset. And so sensors may actually give us an early warning that something is impacting someone's health and that maybe an individual needs to stay at home or be more aware of, of their health in any symptoms that they may develop in the next few days. The studySpeaker 1: 04:19 Is ongoing and we'll look at the impact of vaccines. What are you hoping to find out there?Speaker 2: 04:25 There? Um, we're hoping to better understand the physiological and behavioral response to vaccines as well. Um, to compare Pfizer versus Madrona and also compare users who had, um, uh, COVID infection prior to getting their vaccines, how that may impact their, um, physiological response to receiving the vaccine. Uh, we also want to look at different age groups in different gender, um, look at gender as well to see if there's any differences there in response. And ultimately with that study, we, um, hope to in the future create, um, collect biomarkers. Um, so we can compare the physiological response to perhaps immune response. So we think that this can be maybe in the future a way to understand whether an individual has now did, uh, uh, immune response to, with the vaccine. WhatSpeaker 1: 05:17 Other ways might the information in this study be useful?Speaker 2: 05:21 Yeah, so we are currently partnering with the Rockefeller foundation to increase enrollment on specifically in the San Diego county. And our goal is to create an early warning system where we can identify hotspots of viral illness, infection in different communities faster than traditional, um, viral illness detection. So, um, typically, um, surveillance for viral illnesses, um, relies on or relies on people seeking care from their healthcare provider and their healthcare provider, then reporting the number of people they see each week that meet a certain case definition, as well as those who, um, receive testing for COVID and flu. And that system, the traditional system is actually pretty delayed. It takes about one to three weeks before those data are collected and reported. And so we're hoping that with our wearable data, that we can provide an earlier warning in an earlier detection of, um, local outbreak outbreaks that may occur from new strains of COVID, um, or other viral infections, such as flu epidemicsSpeaker 1: 06:29 And Dr. Rodan, how can people sign up for this study?Speaker 2: 06:32 Yeah, they can go to our research app, which is called my data helps, or you can go to our website, um, detect study.org, and that will direct you to our research app and participants, um, can download our app and then they go through an e-consent process where they learn about our study, and then after that they can share, um, their device data. So we are device agnostic. We can pull in any wearable device that connects to apple health kit or Google fit, and then participants can share with us, um, any symptoms. They may develop vaccination status, any, um, COVID test or flu tests they may receive. And, um, this allows us to compare both the sensor data to what participants are experiencingSpeaker 1: 07:20 Speaking with Jennifer Raiden and epidemiologist with the digital medicine division at scripts research translational Institute, who is leading the detect study. Dr. Raden thanks so much. Thank you.Speaker 3: 07:38 After more than a year of pandemic lockdowns and anxieties signs are emerging that the stress has taken a toll on mental health and personal behaviors. One of the worst examples of that is the increase in San Diego county of drug overdose deaths from fentanyl abuse county statistics show that deaths from the synthetic opioid more than doubled in the past two years, while seizures of the drug along the San Diego, Mexico border, continue to rise county health officials project the number of deaths due to fentanyl overdose. This year, we'll reach a staggering 700 people joining me to explain more about this drug and its lethal potential is Dr. Carla Marian Feld, a board certified addiction psychiatrist at UC San Diego who specializes in the treatment of substance abuse, Dr. Marian felled, welcome to the program. Thank you for having me now, how is fentanyl related to heroin and other opioidSpeaker 2: 08:36 Drugs? Opioids are any class of medicines that can act on the opioid receptor in the brain. And some of them are derived from natural sources like the poppy plant. So things like morphine and heroin, and to some extent, coding fentanyl is a synthetic opioid. So its structure is different, but still acts on the same receptor in the brain. The difference with fentanyl versus some of the naturally derived opioids, is that it's much more potent. So you just need a very, very small amount to achieve a high or a pleasurable effect. And you just need a tiny, tiny bit more to actually overdose or have a very negative effect. Is it cheaper than say heroin? It's cheaper in the sense that you need much less to have a similar effect. So in many ways it ends up being a cheaper product to have a more effective, efficient, high, but with greater risks. And isSpeaker 3: 09:33 The reason that there are so many overdoses is because people are unfamiliar in how to use this as opposed to heroin.Speaker 2: 09:41 I think that there's greater public knowledge about the risks of fentanyl, but there's also a mix of people who are using it. So for some people in the community, there is a preference for fentanyl because it is potent and it's a preferable high. They end up using it without really knowing or recognizing that it's in the supply of heroin or other opioids that they might be obtaining or increasingly where we're seeing it as in the supply of methamphetamine that people are using. But for some they're not necessarily aware, does fentanyl have any legitimate use? It's been around for a long time as a very helpful analgesic for patients with cancer pain, or other types of chronic pain. It wasn't till about 2013 that somebody realized the cheaper, more potent high that you could get with fentanyl. And it started coming into our illicit drug supply. And that's where we really saw this dramatic rise in opioid overdoses that had been steadily increasing since the early two thousands with oxycodone and with heroin, but just dramatically increased with the introduction of fentanyl to the illicit supply in 2013. What kinds ofSpeaker 3: 10:51 Challenges does fentanyl addiction present when treating someone for substance abuse?Speaker 2: 10:56 It actually makes things a lot more complicated. Unlike many other addictions, we actually have really good medications to help people with opioid use disorders with opioids. We have methadone, we have buprenorphine and we have once monthly injectable naltrexone. And these are all three medications that have dramatic benefits to reducing opioid cravings, reducing opioid overdoses, reducing mortality, improving life functioning, et cetera. So the challenge with fentanyl is that it's much harder to get patients started on these medications. Doctor,Speaker 3: 11:31 What are you finding out about the pandemic's effect on opioid addiction?Speaker 2: 11:36 We've had signals since early on in the pandemic of worsening rates of substance use across all substances. Particularly alcohol has made a lot of press, but we've seen it with opioid use disorder as well. The pandemic has done many things. It's interrupted drug supplies. So people are more likely to have disruptions in their use, which can lead to some desperate behaviors or trying to obtain things that are more risky. For example, in addition with all of the stressors that everyone in our society is facing isolation, mental health, et cetera, those things are already things that exacerbate substance use disorders and were just intensified and increased during the pandemic. You mentionedSpeaker 3: 12:20 Fentanyl is new in terms of opioids. And when we know about heroin, we know about Oxycontin, but fentanyl is basically the new drug on our streets. Are we still catching up in terms of how we go about addressing this problem in our community?Speaker 2: 12:35 So fentanyl is newer to San Diego because we have some interesting dynamics in San Diego where methamphetamine has been such a prevalent substance of misuse. And there's been a lot of access to that because fentanyl is so potent, you need just a small amount of it. So it's actually easier to distribute and smuggle into the country as opposed to the quantities you would need for heroin. And so that's changed what's available in San Diego. So fentanyl was really a big problem in the United States, starting in the early 2010s, particularly around 2013, but we're sort of catching up in San Diego now that it's easier for it to be coming here. And we are seeing these change in what people are using in our community. And now I think we're just seeing a continuing legacy of that. That's been exacerbated by the pandemic.Speaker 3: 13:29 I've working with Dr. Carla Marian Feld, a board certified addiction psychiatrist at UC SD and Dr. Marian Feld. Thank you verySpeaker 2: 13:37 Much. Thank you for having me.Speaker 3: 13:40 UC schools should accept more California students. That's the cry from critics. Who've watched the number of out of state and international students climb at state universities in this year's budget, California legislators included funding language that orders UC San Diego, UCLA, and UC Berkeley to cut their out of state undergraduate admissions by about 4% estimates are that will free up a total of 4,500 extra California admissions. And the budget also sets a target of expanding UC admissions in the next two years by more than 6,000 students. And all of them must come from California. Joining me is San Diego union Tribune, reporter Gary Robbins and Gary. Welcome. Thank you so much. How much have out of state and international admissions increased at UC San Diego?Speaker 4: 14:32 It's been explosive. Um, over the past 10 years, the number of international students for example, has gone from about 2000. We have to 8,000, the number of California residents has increased by about 5,000, excuse me, 500 students up to approximately 2000. So a lot of the growth of the university has been from people who are from outside the state of California,Speaker 3: 14:53 And is the increase in those Steve students, all about the extra tuition that they bring to the school.Speaker 4: 15:00 And it is mostly about that, but not entirely. So this is a dilemma with taxpayers. Taxpayers are saying that they want more of their kids allowed into the UC, the people that qualify, but at the same time, over the past 20 years, taxpayers have also been saying, well, we really don't want you to increase the funding for the UC system that pressured the UC system, particularly some of the larger campuses into going elsewhere, like out of state and internationally, uh, to bring in students who pay more than a two and a half times intuition. So it's partly that they're also trying to create universities here that have a more global outlook, particularly in San Diego, which is a Pacific rim, a city and a city on the border, but it is this mostly has to do with money.Speaker 3: 15:44 And how does this new state budget compensate the UCS for cutting out-of-state admissions?Speaker 4: 15:51 So it appears that the state assumes that it's going to cost about $184,000 over the next four years for the three campuses to reduce the number of undergraduates from other places and replace them with California's. They haven't appropriated all of that money, but the legislature is on track to do that. So they're essentially buying out the out of state and international students.Speaker 3: 16:14 Why exactly is there criticism about the number of out-of-state UC admissions and where is that criticism coming from?Speaker 4: 16:22 A lot of the criticism comes from prospective students and from their parents. Um, they've rightfully point to the fact that their children would qualify for entrance into the UC system under the current standards. And California, as you know, has been growing and the number of high school graduates who qualify for the UC has been improving. So there's quite a pipeline of, um, California based students who want to get into the UC. And many of those students want to get into particular schools like the Hoya, UCLA and Berkeley they're are considered to be the most prestigious and, um, a school like San Diego has been growing so fast. There's just a lot of dynamic energy there. And people are seeing it as a place that is really a fun and interesting place